<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Press Releases

Press Releases    Advancement    Neuro-Ophthalmology

CU School of Medicine Names Inaugural Endowed Chair in Department of Ophthalmology

Prem Subramanian, MD, PhD, professor and vice chair for academic affairs in the Department of Ophthalmology at the University of Colorado School of Medicine, has been named the inaugural Clifford R. and Janice N. Merrill Endowed Chair in Ophthalmology.


Author Toni Lapp | Publish Date September 23, 2022
Full Story

Innovation    Press Releases    Health Sciences   

Jayashree Kalpathy-Cramer, PhD, Named Chief of Artificial Medical Intelligence in Ophthalmology

Jayashree Kalpathy-Cramer, PhD, has been named chief of the new Division of Artificial Medical Intelligence in Ophthalmology at the University of Colorado (CU) School of Medicine. In her new role, Kalpathy-Cramer will translate novel artificial intelligence (AI) methods into effective patient care practices at the Sue Anschutz-Rodgers Eye Center.


Author Rachel Wittel | Publish Date March 17, 2022
Full Story

Press Releases    Community    Faculty

CU Ophthalmology Professor Named Chair of the Orbis Medical Advisory Committee

Malik Y. Kahook, MD, professor of ophthalmology and the Slater Family Endowed Chair in Ophthalmology at the University of Colorado School of Medicine, has been named chair of the Orbis Medical Advisory Committee. A global non-profit, Orbis International focuses on prevention and treatment of avoidable blindness through training, education, and advocacy, especially in low- and middle-income countries.


Author Rachel Wittel | Publish Date January 25, 2022
Full Story

See Us In the News

Ophthalmology Times

Horizon offers update on TED treatment option

news outletOphthalmology Times
Publish DateMay 04, 2023

CU Department of Ophthalmology Professor Prem Subramanian, MD, PhD, discusses a double-masked randomized placebo controlled trial of the use of TEPEZZA in patients with a much longer duration of thyroid eye disease than those who are enrolled in the phase 2 and phase 3 studies that lead to FDA approval.

Full Story
SPIE

Toward fairness in artificial intelligence for medical image analysis: Identification and mitigation of potential biases in the roadmap from data collection to model deployment

news outletSPIE
Publish DateApril 28, 2023

Researchers, including the Department of Ophthalmology's Jayashree Kalpathy-Cramer, examine how artificial intelligence and machine learning (AI/ML) in medical imaging provide important methods for leveraging large amounts of data to build models to detect disease and provide diagnosis, prognosis, and risk assessment tools to support decision-making in medicine. 

Full Story
The Royal Australian and New Zealand College of Ophthalmologists

The use of social and digital media to recruit patients with early and intermediate age-related macular degeneration

news outletThe Royal Australian and New Zealand College of Ophthalmologists
Publish DateApril 27, 2023

The University of Colorado Ophthalmology Social Media Research Group, led by Anne Lynch, MD, publishes a Letter to the Editor in the Retinal Issue of Clinical and Experimental Ophthalmology 

Full Story
Science Direct

Impact of cosmetics on the ocular surface

news outletScience Direct
Publish DateApril 26, 2023

Today, eye cosmetics, or makeup, comprise a diverse array of products. They include concealers, conditioners, creams, extensions, eyeliners, foundations, glues, mascaras, primers, removers, serums, shadows, and toners. A number of the ingredients in these products may be harmful to the ocular surface and adnexa.

Full Story